Literature DB >> 1118043

Direct evidence for the specific fixation of Cl. botulinum A neurotoxin to brain matter.

E Habermann, I Heller.   

Abstract

Rat brain homogenate and synaptosomes from rat brain bind botulinum toxin. The binding is accompanied by partial inactivation. The binding decreases with increasing ionic strength. A considerable fixation of tetanus toxin can still be demonstrated under conditions which prevent the fixation of botulinum toxin. 2. Only the grey substance, not the white substance from bovine brain is able to bind the toxin. 3. Upon pretreatment with neuraminidase, synaptosomes lose nearly all of their binding capacity. However, neither gangliosides nor ganglioside-cerebroside mixtures nor brain extracts could replace the synaptosomes. Thus botulinum A toxin closely resembles tetanus toxin in its ability to react with (a) neuraminidase-sensitive site(s) of the grey matter of the CNS. It differs from tetanus toxin by its stronger sensitivity against ionic forces and by its failure to react with certain gangliosides.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1118043     DOI: 10.1007/bf00632641

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  A note on the specific fixation, specific deactivation and non-specific inactivation of bacterial toxins by gangliosides.

Authors:  W E van Heyningen; J Mellanby
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

2.  Ganglioside inactivation of botulinum toxin.

Authors:  L L Simpson; M M Rapport
Journal:  J Neurochem       Date:  1971-07       Impact factor: 5.372

3.  125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord.

Authors:  E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Proceedings: Type A botulinum toxin in cats: neural ascent and action on spinal cord reflexes.

Authors:  H Wiegand; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Interaction of labelled tetanus toxin and toxoid with substructures of rat brain and spinal cord in vitro.

Authors:  E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  On the similarity of tetanus and botulinum toxins.

Authors:  J Mellanby; P A Thompson; N Hampden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids.

Authors:  L L Simpson; M M Rapport
Journal:  J Neurochem       Date:  1971-09       Impact factor: 5.372

8.  The binding of botulinum toxin to membrane lipids: phospholipids and proteolipid.

Authors:  L L Simpson; M M Rapport
Journal:  J Neurochem       Date:  1971-09       Impact factor: 5.372

9.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

  9 in total
  13 in total

1.  beta-Bungarotoxin, a pre-synaptic toxin with enzymatic activity.

Authors:  P N Strong; J Goerke; S G Oberg; R B Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

2.  Binding of botulinum neurotoxin to the synaptosome fraction of rat brain.

Authors:  M Kitamura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-11       Impact factor: 3.000

3.  Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones.

Authors:  R Hagenah; R Benecke; H Wiegand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

4.  The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex.

Authors:  H Wiegand; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

5.  Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors.

Authors:  W E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

Review 6.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

7.  Botulism: clinical neurophysical findings.

Authors:  R Hagenah; A Müller-Jensen
Journal:  J Neurol       Date:  1978-02-14       Impact factor: 4.849

8.  Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin.

Authors:  E Habermann; H Bigalke; I Heller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

9.  Topographic studies of gangliosides of intact synaptosomes from rat brain cortex.

Authors:  B L Hungund; S P Mahadik
Journal:  Neurochem Res       Date:  1981-02       Impact factor: 3.996

10.  125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection.

Authors:  H Wiegand; G Erdmann; H H Wellhöner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.